Cowen Upgrades Jazz Pharmaceuticals (JAZZ) to Outperform

September 11, 2012 9:51 AM EDT Send to a Friend
Get Alerts JAZZ Hot Sheet
Price: $170.10 +0.15%

Rating Summary:
    22 Buy, 5 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 18 | New: 41
Trade JAZZ Now!
Join SI Premium – FREE
Cowen upgraded Jazz Pharmaceuticals (NASDAQ: JAZZ) from Neutral to Outperform.

For an analyst ratings summary and ratings history on Jazz Pharmaceuticals click here. For more ratings news on Jazz Pharmaceuticals click here.

Shares of Jazz Pharmaceuticals closed at $43.56 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Upgrades

Related Entities

Cowen & Co

Add Your Comment